Phase 1- Solution Design

This Phase has been completed.

The summaries of the Solution Designs can be viewed here

 

Duration: 16th April to 16th October 2022   

During Phase 1 the Contractors will perform research to:

  1. elaborate the solution design and determine the approach to be taken to develop the new solutions and
  2. demonstrate the technical, financial and commercial feasibility of the proposed concepts and approach to meet the procurement need.

Information for Contractors

Contract Award Notice

Phase 1 Awards 

Budget of awarded contracts: 610 246.65 EUR

Tenders received: 24

Number of Contracts awarded: 15

Lot 1: Pre-Sequencing: 5

Lot 2: Sequencing:  Due to the insufficient number of tenders received, no contract has been awarded in Lot 2.

Lot 3: Bioinformatics Analysis: 5

Lot 4: Integrated Reporting: 5

Selected tenders:

Lot 1: Pre Sequencing 

Agilent-Technologies-Instand-NGS4P-Lot 1 –  Project abstract
Lead: Agilent Technologies R&D Marketing GmbH & Co KG 
 
Lead: Integrated DNA Technologies, BV
 
Lead: QIAGEN GmbH
 

Thermo Fisher Scientific 1-Day NGS  – Project abstract 
Lead: Thermo Fisher Scientific 1-Day NGS

TwistPlatomicsMGI – Project abstract
Lead: Twist Bioscience Corporation
 
 

Lot 3: Bioinformatics Analysis

EU Onco-Platform L3 – Project abstract 
Lead: BC Platforms AG
Consortium members: Euformatics Oy, Oncompass Medicine Hangary Kft.
 
Congenica L3 – Project abstract
Lead: Congenica Limited BIC Wellcome Genome Campus
Consortium members: Single tenderer 
 
Cancer Analysis GPAP – Project abstract
Lead: FUNDACIO CENTRE DE REGULACIO GENOMICA
Consortium members: Single tenderer 
 
INSPECT – Project abstract
Lead: Phenosystems SA

Consortium members: Maxeler Technologies Ltd., Haute école spécialisée de Suisse occidentale

 
PlatoDKFZCharité – Project abstract 
Lead: Platomics GmbH
Consortium members: Deutsches Krebforschungszentrum, Charité Universitätsmedizin Berlin
 

Lot 4: Integrated Reporting

EU Onco Platform L4 – Project abstract
Lead: BC Platforms AG
Consortium members: Euformatics Oy, Oncompass Medicine Hangary Kft.
 
Congenica L4 – Project abstract
Lead: Congenica Limited BIC Wellcome Genome Campus
Consortium members: Single tenderer 
 
tde4ngs – Project abstract 
Lead: fragmentiX Storage Solutions GmbH 
Consortium members: ID GmbH & Co. KgaA, Maxeler Technologies Ltd., Prime Force GmbH
 
Cancer Reporting GPAP – Project abstract
Lead: FUNDACIO CENTRE DE REGULACIO GENOMICA
Consortium members: Single tenderer 
 
Lead: Saphetor SA
Consortium members: Single tenderer